Nvidia invests $50 million in biotech company Recursion for AI drug discovery
Nvidia is investing in Recursion, which uses AI models to identify new therapies and offers those models to its partners,
Read MoreNvidia is investing in Recursion, which uses AI models to identify new therapies and offers those models to its partners,
Read MoreWhether it's personalized shopping or self-driving cars, AI will become a factor in virtually everyone's lives. Source link
Read MoreOver the next 12 to 18 months, AI-first drug developers will provide updates on early clinical work that will help
Read More